Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Heart Valves01:16

Heart Valves

14.7K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
14.7K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.3K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

913
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
913
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E ε4 allele.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2011
Same author

Evolution of sensory complexity recorded in a myxobacterial genome.

Proceedings of the National Academy of Sciences of the United States of America·2006
Same author

Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D.

International journal of immunopharmacology·2003
Same author

Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.

International immunopharmacology·2002
Same author

Midterm survival of stented versus stentless valves: does concomitant coronary artery bypass grafting impact survival?

Seminars in thoracic and cardiovascular surgery·2002
Same author

Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58.

Science (New York, N.Y.)·2001

関連する実験動画

Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

ステントなしのバルブとステント付きのバルブとの初期の経験

G Cohen1, G T Christakis, K J Buth

  • 1Division of Cardiovascular Surgery, Sunnybrook Health Sciences Centre and The Toronto Hospital, University of Toronto, Ontario, Canada.

Circulation
|December 31, 1997
PubMed
まとめ

トロントのステントなしの豚弁 (SPV) は,ステント付きの弁 (STD) と比較して,大動脈弁の置換後の心室機能の改善を示しました. しかし,この研究では,SPVとSTD群の間で有意な血液動力学的違いは観察されなかった.

さらに関連する動画

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

関連する実験動画

Last Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

科学分野:

  • 心血管外科手術についてです.
  • バイオマテリアル科学 バイオマテリアル科学
  • 医療機器 医療機器について

背景:

  • トロントのステントレス豚弁 (SPV) は,従来のステント付き弁 (STD) と比較してフローエリアを増やすことにより,大動脈弁置換 (AVR) の血液動力学を強化するために開発されました.
  • 血液動力学的パフォーマンスの評価は,AVR後の結果を最適化するために非常に重要です.

研究 の 目的:

  • トロントのステントなしの豚弁 (SPV) と,隔離された大動脈弁置換後のステント付き弁 (STD) の間の血液動力学的性能と心室改造を将来的に比較するために.
  • SPVインプラントと関連した心室力学における潜在的な機能的改善を評価する.

主な方法:

  • 単離AVR (+/-冠動脈バイパス移植) を受けた59人の患者を対象とした前向きな研究.
  • 患者はステント付き弁 (STD,n=23) またはトロントのステントのない豚弁 (SPV,n=36) を受けました.
  • 術前および3〜6ヶ月の術後エコーカルディオグラフィは,血液動力学的パラメータと左心室質量指数を評価するために使用されました.

主要な成果:

  • SPVインプラントは平均で大きかった (26.6mm vs. 24.0mm,P=0.0002).
  • 術後の有効穴の面積は,特にSPV群では (1.9cm2対1.5cm2,P=0.01) 大きく増加した (P=0.0001).
  • 分割縮小と周回縮小の速度で測定された心室機能は,SPV患者で有意に改善した (P=0.0004とP=0.0001).

結論:

  • SPVインプラントは心房機能の改善と関連しているが,SPVとSTD群の間で有意な血液動力学的差異は検出されなかった.
  • 非ランダム化設計は,選択バイアスを導入し,観察された結果に影響を与える可能性があります.
  • 将来のランダム化試験によるさらなる調査は,SPVの血液動力学的利点を決定的に確認するために正当化されています.